Assessment of cardiovascular risk for serious mental disorders

被引:0
作者
Cinar, Rugul Kose [1 ]
Durmus, Pelin Tas [2 ]
机构
[1] Trakya Univ, Tip Fak, Psikiyatri AD, Edirne, Turkey
[2] Besni Devlet Hastanesi, Psikiyatri Bolumu, Adiyaman, Turkey
来源
KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY | 2019年 / 22卷 / 03期
关键词
Framingham risk scoring; C-reactive protein; depression; psychotic disorders; bipolar disorder; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; BIPOLAR DISORDER; SCHIZOPHRENIA; DISEASE; DEPRESSION; MORTALITY; METAANALYSIS; PREVALENCE; STROKE;
D O I
10.5505/kpd.2019.92905
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Incidence and prevalence of cardiovascular diseases in patients with severe mental disorders are higher than the general population. It was aimed to calculate the 10 year cardiovascular disease risk by using Framingham risk scoring (FRS) and investigate the relationship between this score and C-reactive protein in psychiatric inpatients of a university hospital. Method: Inpatients with the diagnosis of major depression, bipolar disorders and psychotic disorders in six months time were included in the study.Participants were assessed based on their gender, age, body mass index, waist circumference, FRS, and CRP levels. Results: The calculated 10 year cardiovascular disease development risk did not differ between the diagnosis (p=0,39), but found to be significantly higher in males than females (p=0,002). FRS levels showed positive correlations with male gender (p=0,002), age (p=0,000), waist circumference (p=0,001), and body mass index (p=0,001). Discussion: We have to evaluate coexisting somatic diseases of psychiatric patients as well as behavioral and psychological problems. Using FRS, evaluating body mass index and waist circumference could help us predict the risky population and we could consider our drug treatment choices accordingly.
引用
收藏
页码:260 / 265
页数:6
相关论文
共 31 条
  • [1] Reducing the Mortality Gap in People With Severe Mental Disorders: The Role of Lifestyle Psychosocial Interventions
    Barber, Sarah
    Thornicroft, Graham
    [J]. FRONTIERS IN PSYCHIATRY, 2018, 9
  • [2] Schizophrenia, antipsychotic drugs and cardiovascular risk: Descriptive study in primary care
    Castillo-Sanchez, M.
    Fabregas-Escurriola, M.
    Berge-Baquero, D.
    Foguet-Boreu, Q.
    Fernandez-San Martin, M. I.
    Goday-Arno, A.
    [J]. EUROPEAN PSYCHIATRY, 2015, 30 (04) : 535 - 541
  • [3] Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London
    Chang, Chin-Kuo
    Hayes, Richard D.
    Perera, Gayan
    Broadbent, Mathew T. M.
    Fernandes, Andrea C.
    Lee, William E.
    Hotopf, Mathew
    Stewart, Robert
    [J]. PLOS ONE, 2011, 6 (05):
  • [4] Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls
    Correll, Christoph U.
    Solmi, Marco
    Veronese, Nicola
    Bortolato, Beatrice
    Rosson, Stella
    Santonastaso, Paolo
    Thapa-Chhetri, Nita
    Fornaro, Michele
    Gallicchio, Davide
    Collantoni, Enrico
    Pigato, Giorgio
    Favaro, Angela
    Monaco, Francesco
    Kohler, Cristiano
    Vancampfort, Davy
    Ward, Philip B.
    Gaughran, Fiona
    Carvalho, Andre F.
    Stubbs, Brendon
    [J]. WORLD PSYCHIATRY, 2017, 16 (02) : 163 - 180
  • [5] General cardiovascular risk profile for use in primary care - The Framingham Heart Study
    D'Agostino, Ralph B.
    Vasan, Ramachandran S.
    Pencina, Michael J.
    Wolf, Philip A.
    Cobain, Mark
    Massaro, Joseph M.
    Kannel, William B.
    [J]. CIRCULATION, 2008, 117 (06) : 743 - 753
  • [6] Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
    De Hert, Marc
    Detraux, Johan
    van Winkel, Ruud
    Yu, Weiping
    Correll, Christoph U.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2012, 8 (02) : 114 - 126
  • [7] Schizophrenia and the risk of cardiovascular diseases: A meta-analysis of thirteen cohort studies
    Fan, Zuoxu
    Wu, Yaoyao
    Shen, Jian
    Ji, Tao
    Zhan, Renya
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (11) : 1549 - 1556
  • [8] C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
    Fernandes, B. S.
    Steiner, J.
    Bernstein, H-G
    Dodd, S.
    Pasco, J. A.
    Dean, O. M.
    Nardin, P.
    Goncalves, C-A
    Berk, M.
    [J]. MOLECULAR PSYCHIATRY, 2016, 21 (04) : 554 - 564
  • [9] The cardiovascular and respiratory health of people with schizophrenia
    Filik, R
    Sipos, A
    Kehoe, PG
    Burns, T
    Cooper, SJ
    Stevens, H
    Laugharne, R
    Young, G
    Perrington, S
    McKendrick, J
    Stephenson, D
    Harrison, G
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2006, 113 (04) : 298 - 305
  • [10] Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysis
    Foguet-Boreu, Quinti
    Fernandez San Martin, Maria Isabel
    Flores Mateo, Gemma
    Zabaleta del Olmo, Edurne
    Garcia-Morzon, Luis Ayerbe
    Lopez, Maria Perez-Pinar
    Miguel Martin-Lopez, Luis
    Montes Hidalgo, Javier
    Violan, Concepcion
    [J]. BMC PSYCHIATRY, 2016, 16